Portfolio Details

Saranas

Saranas company logo
Current

Saranas is a privately held medical device company focusing on improving patient outcomes through early detection and monitoring of internal bleeding complications.

Baird Capital invests in the Technology & Services sector, including tech business services, as well as businesses that provide services directly or indirectly to the healthcare industry. Baird Capital and predecessor entities previously made investments in MedTech including investments in medical tools (e.g., DNA analysis), Medical devices (e.g., bladder control, heart valves, surgical robotics, etc.) and certain areas of Industrials and Consumer Products. 

Learn more about the company
Saranas company logo
Current
Team
Venture Capital
Invested Date
July 2021
Status
Active
Location
U.S.

Share

See All Transactions

Related Content

Saranas Announces Clinical Trial Initiation

Saranas, Inc., announced initiation and first patient enrollment in SAFE-MCS.

Computers screen showing a skeletal scan
Venture Capital Team Invests in Saranas

Our Venture Capital team led a $12.8MM Series B investment in Saranas, a Houston-based pioneering medical device company.